Stocks took an early hit on news that ChatGPT parent OpenAI might push its public offering to 2027, and a midday recovery faded into the close.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
533last 24h
2517last 7d
483● bullish (7d)
255● bearish (7d)
197publishers
Kiplinger39d agoneutral
Stocks Struggle After OpenAI IPO Blow: Stock Market TodayMotley Fool54d agobullish
Parabilis Soared 58% in the Biggest Biotech IPO on Record. Is It Too Late to Buy the Stock?It's important to consider your comfort with risk before diving in.
Barchart54d agoneutral
How to Play PBLS Stock After the Parabilis IPOParabilis stock soared on its Nasdaq debut, but a deeper dive suggests PBLS shares could extend gains further through the remainder of 2026.
BioPharma Dive56d agoneutral
Parabilis sets a record with a $670M biotech IPOThe largest-ever new stock sale for a venture-backed biotech company extends a streak of large IPOs in 2026 that’s now resulted in 12 drug startups securing more than $4.1 billion combined.